Protracted administration of L-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia

Hideki Yoshida, Toshihiko Imamura, Akiko M. Saito, Yoshihiro Takahashi, Soichi Suenobu, Daiichiro Hasegawa, Takao Deguchi, Yoshiko Hashii, Hirohide Kawasaki, Mikiya Endo, Hiroki Hori, Nobuhiro Suzuki, Yoshiyuki Kosaka, Koji Kato, Keiko Yumura-Yagi, Junichi Hara, Megumi Oda, Atsushi Sato, Keizo Horibe

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether the profile of this adverse event is affected by intensification of L-asparaginase administration. Here, we analyzed the profile of L-asparaginase related hyperglycemia in a 1,176 patients with pediatric acute lymphoblastic leukemia treated according to the Japan Association of Childhood Leukemia Study ALL-02 protocol using protracted L-asparaginase administration in maintenance phase. We determined that a total of 75 L-asparaginase related hyperglycemia events occurred in 69 patients. Although 17 events (17/1176,1.4%) developed in induction phase, which was lower incidence than those (10-15%) in previous reports, 45 events developed during the maintenance phase with protracted L-asparaginase administration. Multivariate analysis showed that older age at onset (≥ 10 years) was a sole independent risk factor for L-asparaginase-related hyperglycemia (P<0.01), especially in maintenance phase. Contrary to the previous reports, obesity was not associated with L-asparaginase-related hyperglycemia. These findings suggest that protracted administration of L-asparaginase is the risk factor for hyperglycemia when treating adolescent and young adult acute lymphoblastic leukemia patients.

Original languageEnglish
Article numbere0136428
JournalPloS one
Volume10
Issue number8
DOIs
Publication statusPublished - Aug 28 2015
Externally publishedYes

Fingerprint

asparaginase
Asparaginase
lymphocytic leukemia
Pediatrics
hyperglycemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Hyperglycemia
risk factors
Maintenance
leukemia
young adults
Age of Onset
childhood
multivariate analysis
Young Adult
Japan
Leukemia
obesity
Multivariate Analysis
Obesity

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Protracted administration of L-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia. / Yoshida, Hideki; Imamura, Toshihiko; Saito, Akiko M.; Takahashi, Yoshihiro; Suenobu, Soichi; Hasegawa, Daiichiro; Deguchi, Takao; Hashii, Yoshiko; Kawasaki, Hirohide; Endo, Mikiya; Hori, Hiroki; Suzuki, Nobuhiro; Kosaka, Yoshiyuki; Kato, Koji; Yumura-Yagi, Keiko; Hara, Junichi; Oda, Megumi; Sato, Atsushi; Horibe, Keizo.

In: PloS one, Vol. 10, No. 8, e0136428, 28.08.2015.

Research output: Contribution to journalArticle

Yoshida, H, Imamura, T, Saito, AM, Takahashi, Y, Suenobu, S, Hasegawa, D, Deguchi, T, Hashii, Y, Kawasaki, H, Endo, M, Hori, H, Suzuki, N, Kosaka, Y, Kato, K, Yumura-Yagi, K, Hara, J, Oda, M, Sato, A & Horibe, K 2015, 'Protracted administration of L-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia', PloS one, vol. 10, no. 8, e0136428. https://doi.org/10.1371/journal.pone.0136428
Yoshida, Hideki ; Imamura, Toshihiko ; Saito, Akiko M. ; Takahashi, Yoshihiro ; Suenobu, Soichi ; Hasegawa, Daiichiro ; Deguchi, Takao ; Hashii, Yoshiko ; Kawasaki, Hirohide ; Endo, Mikiya ; Hori, Hiroki ; Suzuki, Nobuhiro ; Kosaka, Yoshiyuki ; Kato, Koji ; Yumura-Yagi, Keiko ; Hara, Junichi ; Oda, Megumi ; Sato, Atsushi ; Horibe, Keizo. / Protracted administration of L-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia. In: PloS one. 2015 ; Vol. 10, No. 8.
@article{94b6248a1ff64574b562ea4b54a8421b,
title = "Protracted administration of L-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia",
abstract = "Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether the profile of this adverse event is affected by intensification of L-asparaginase administration. Here, we analyzed the profile of L-asparaginase related hyperglycemia in a 1,176 patients with pediatric acute lymphoblastic leukemia treated according to the Japan Association of Childhood Leukemia Study ALL-02 protocol using protracted L-asparaginase administration in maintenance phase. We determined that a total of 75 L-asparaginase related hyperglycemia events occurred in 69 patients. Although 17 events (17/1176,1.4{\%}) developed in induction phase, which was lower incidence than those (10-15{\%}) in previous reports, 45 events developed during the maintenance phase with protracted L-asparaginase administration. Multivariate analysis showed that older age at onset (≥ 10 years) was a sole independent risk factor for L-asparaginase-related hyperglycemia (P<0.01), especially in maintenance phase. Contrary to the previous reports, obesity was not associated with L-asparaginase-related hyperglycemia. These findings suggest that protracted administration of L-asparaginase is the risk factor for hyperglycemia when treating adolescent and young adult acute lymphoblastic leukemia patients.",
author = "Hideki Yoshida and Toshihiko Imamura and Saito, {Akiko M.} and Yoshihiro Takahashi and Soichi Suenobu and Daiichiro Hasegawa and Takao Deguchi and Yoshiko Hashii and Hirohide Kawasaki and Mikiya Endo and Hiroki Hori and Nobuhiro Suzuki and Yoshiyuki Kosaka and Koji Kato and Keiko Yumura-Yagi and Junichi Hara and Megumi Oda and Atsushi Sato and Keizo Horibe",
year = "2015",
month = "8",
day = "28",
doi = "10.1371/journal.pone.0136428",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Protracted administration of L-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia

AU - Yoshida, Hideki

AU - Imamura, Toshihiko

AU - Saito, Akiko M.

AU - Takahashi, Yoshihiro

AU - Suenobu, Soichi

AU - Hasegawa, Daiichiro

AU - Deguchi, Takao

AU - Hashii, Yoshiko

AU - Kawasaki, Hirohide

AU - Endo, Mikiya

AU - Hori, Hiroki

AU - Suzuki, Nobuhiro

AU - Kosaka, Yoshiyuki

AU - Kato, Koji

AU - Yumura-Yagi, Keiko

AU - Hara, Junichi

AU - Oda, Megumi

AU - Sato, Atsushi

AU - Horibe, Keizo

PY - 2015/8/28

Y1 - 2015/8/28

N2 - Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether the profile of this adverse event is affected by intensification of L-asparaginase administration. Here, we analyzed the profile of L-asparaginase related hyperglycemia in a 1,176 patients with pediatric acute lymphoblastic leukemia treated according to the Japan Association of Childhood Leukemia Study ALL-02 protocol using protracted L-asparaginase administration in maintenance phase. We determined that a total of 75 L-asparaginase related hyperglycemia events occurred in 69 patients. Although 17 events (17/1176,1.4%) developed in induction phase, which was lower incidence than those (10-15%) in previous reports, 45 events developed during the maintenance phase with protracted L-asparaginase administration. Multivariate analysis showed that older age at onset (≥ 10 years) was a sole independent risk factor for L-asparaginase-related hyperglycemia (P<0.01), especially in maintenance phase. Contrary to the previous reports, obesity was not associated with L-asparaginase-related hyperglycemia. These findings suggest that protracted administration of L-asparaginase is the risk factor for hyperglycemia when treating adolescent and young adult acute lymphoblastic leukemia patients.

AB - Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether the profile of this adverse event is affected by intensification of L-asparaginase administration. Here, we analyzed the profile of L-asparaginase related hyperglycemia in a 1,176 patients with pediatric acute lymphoblastic leukemia treated according to the Japan Association of Childhood Leukemia Study ALL-02 protocol using protracted L-asparaginase administration in maintenance phase. We determined that a total of 75 L-asparaginase related hyperglycemia events occurred in 69 patients. Although 17 events (17/1176,1.4%) developed in induction phase, which was lower incidence than those (10-15%) in previous reports, 45 events developed during the maintenance phase with protracted L-asparaginase administration. Multivariate analysis showed that older age at onset (≥ 10 years) was a sole independent risk factor for L-asparaginase-related hyperglycemia (P<0.01), especially in maintenance phase. Contrary to the previous reports, obesity was not associated with L-asparaginase-related hyperglycemia. These findings suggest that protracted administration of L-asparaginase is the risk factor for hyperglycemia when treating adolescent and young adult acute lymphoblastic leukemia patients.

UR - http://www.scopus.com/inward/record.url?scp=84943228343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943228343&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0136428

DO - 10.1371/journal.pone.0136428

M3 - Article

C2 - 26317422

AN - SCOPUS:84943228343

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e0136428

ER -